Blood Collection Devices Market by Product Type, Technology, Material, Application, End Users

List of Tables

The Blood Collection Devices Market was valued at USD 7.74 billion in 2024 and is projected to grow to USD 8.18 billion in 2025, with a CAGR of 5.94%, reaching USD 10.95 billion by 2030.

Executive Summary: Introduction to the Blood Collection Devices Market

KEY MARKET STATISTICS
Base Year [2024]	USD 7.74 billion
Estimated Year [2025]	USD 8.18 billion
Forecast Year [2030]	USD 10.95 billion
CAGR (%)	5.94%

The global blood collection devices industry stands at the crossroads of innovation and critical healthcare delivery. Over the past few years, the market has undergone a remarkable transformation driven by technological advancements, rigorous quality standards, and an ever-increasing focus on patient safety. This comprehensive introduction provides an overview of an industry that plays a pivotal role in clinical diagnostics and therapeutic applications. New materials, improved design standards, and enhanced safety protocols have not only redefined how blood samples are collected but have also widened the scope of their usability. With healthcare systems worldwide mandating accuracy and rapid turnaround in diagnostics, blood collection devices have become an essential component of modern medicine.

The evolution of the market reflects a concerted effort to bridge the gap between technological innovation and functional design. As regulatory frameworks become more stringent, manufacturers are prioritizing product quality and adherence to global standards. This drive has resulted in improvements in performance, reliability, and efficiency. Market leaders have invested significantly in research and development, leading to devices that not only reduce risks of contamination but are also more ergonomic for healthcare providers. Such advancements have provided decision-makers and industry stakeholders with robust options to meet diverse clinical needs, thereby ensuring that patient care remains uncompromised.

Transformative Shifts in the Blood Collection Devices Landscape

Over recent years, the blood collection devices landscape has experienced transformative shifts characterized by rapid technological integration and evolving healthcare practices. This era of transformation converges around the dual axes of innovation and heightened regulatory expectations. The increased reliance on automated systems is reshaping traditional processes, as digital integration enhances precision in sample collection and processing. Advances in automation have complemented improvements in material sciences, resulting in devices with greater durability, better biocompatibility, and improved safety profiles.

Concurrently, market forces and competitive pressures have compelled manufacturers to reexamine the entire value chain-from design and production to logistics and after-sales support. Modern devices now incorporate features that facilitate seamless connectivity with healthcare information systems, ensuring real-time monitoring and enhanced traceability of samples. These shifts are also a direct response to the growing demand for minimally invasive procedures and enhanced patient comfort. With an industry that is rapidly moving away from traditional manual techniques, the infusion of automation and smart technologies represents a significant leap forward in efficiency and reliability. As trends continue to solidify, these transformative changes are redefining competitive benchmarks and customer expectations in the evolving landscape of blood collection technology.

Key Segmentation Insights for the Blood Collection Devices Market

In-depth market analysis reveals a multifaceted segmentation that paints a complete picture of the blood collection devices market. A detailed evaluation based on product type highlights categories including blood bags, blood collection needles, blood collection tubes, and blood lancets. Among these, the blood collection needles segment is further refined into syringe needles and vacuum needles, each addressing specific needs within clinical practice. Equally, blood collection tubes are scrutinized in sub-sections that span EDTA tubes, Heparin tubes, plasma blood tubes, and serum tubes, providing essential functionalities tailored to various diagnostic requirements.

Further segmentation driven by technology differentiates the market into automated blood collection devices and manual blood collection devices. This technological bifurcation emphasizes the trend toward higher precision and efficiency offered by automation while underscoring the continued relevance of manual devices in cost-sensitive settings. Material-based segmentation introduces another layer of complexity with products manufactured from glass, plastic, rubber, and stainless steel, each chosen for its specific properties to meet safety, durability, and usability standards. Analysis based on application divides the market into segments catering to diagnostics and therapeutics, wherein each segment is fine-tuned to support different clinical scenarios. Additionally, a review of end users identifies primary stakeholders such as blood donation centers, diagnostic centers and pathology laboratories, and hospitals and clinics, each with unique operational requirements. This comprehensive segmentation framework presents a clear view of where innovation, targeted research, and strategic investments can yield the most significant impact on both market growth and clinical outcomes.

Based on Product Type, market is studied across Blood Bags, Blood Collection Needles, Blood Collection Tubes, and Blood Lancets. The Blood Collection Needles is further studied across Syringe Needles and Vacuum Needles. The Blood Collection Tubes is further studied across EDTA Tubes, Heparin Tubes, Plasma Blood Tubes, and Serum Tubes.

Based on Technology, market is studied across Automated Blood Collection Devices and Manual Blood Collection Devices.

Based on Material, market is studied across Glass, Plastic, Rubber, and Stainless Steel.

Based on Application, market is studied across Diagnostics and Therapeutics.

Based on End Users, market is studied across Blood Donation Centers, Diagnostic Centers & Pathology Laboratory, and Hospitals & Clinics.

Key Regional Insights of the Global Blood Collection Devices Market

Examining regional trends offers a nuanced understanding of the market dynamics across different geographies. In the Americas, technological advancements combined with robust healthcare infrastructure drive significant market growth as the region continues to prioritize both quality and efficiency in clinical settings. The region exhibits strong demand for advanced blood collection systems that can seamlessly integrate with established healthcare protocols, ultimately enhancing patient outcomes.

In the combined regions of Europe, the Middle East, and Africa, a strong focus on regulatory compliance and healthcare standardization acts as a catalyst for innovation. These areas are characterized by rapid adoption of new technologies to meet stringent safety requirements while balancing cost and operational efficiency. Meanwhile, the Asia-Pacific region presents a compelling growth narrative fueled by an expanding population, increasing disposable income, and a focused drive to upgrade healthcare infrastructure. Rapid urbanization in this area is fostering an environment where modern blood collection devices are increasingly in demand, addressing both diagnostic and therapeutic needs. Taken together, these regional insights underscore the complexity of market trends while highlighting significant regional drivers that shape investment strategies and competitive positioning across the blood collection devices landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Blood Collection Devices Market

The competitive landscape of the blood collection devices market is defined by a blend of established global giants and innovative emerging players. Industry titans such as Abbott Laboratories and Becton, Dickinson and Company have consistently driven product innovation, supported by substantial investments in research and development. Their commitment to quality and precision has established them as reliable choices within the clinical ecosystem. Companies like Avanos Medical, Inc. and Medtronic PLC have further advanced the integration of sophisticated automation and technological interfacing in their devices, aligning with the market's shift towards digital solutions.

Other key players including AdvaCare Pharma, Avantor, Inc., and B. Braun SE have strategically positioned themselves by diversifying their product portfolios to address various clinical needs. Firms such as Fresenius SE & Co. KGaA and Greiner AG provide robust solutions that emphasize performance reliability and operator safety. Notably, organizations like Cardinal Health, Inc., ICU Medical, Inc., and Thermo Fisher Scientific Inc. have harnessed advanced manufacturing techniques and streamlined supply chains to enhance both the cost-efficiency and accessibility of their products. Furthermore, companies such as Bio-Rad Laboratories, Inc. and Siemens Healthineers AG continually set new benchmarks by incorporating next-generation materials and innovative design features. This competitive environment, where traditional expertise meets agile innovation, creates a dynamic market that encourages continuous improvement and alignment with evolving healthcare demands.

The report delves into recent significant developments in the Blood Collection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Avanos Medical, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biosigma S.p.A., Cardinal Health, Inc., Exelint International, Co., Fresenius SE & Co. KGaA, Greiner AG, Haemonetics Corporation by GVS S.p.A., ICU Medical, Inc., Kawasumi Laboratories America, Inc., Lasany International, Medtronic PLC, Merit Medical Systems, Inc., Nipro Corporation, Sarstedt AG & Co. KG, Sekisui Medical Co., Ltd., Siemens Healthineers AG, Terumo Corporation, and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders in Blood Collection Devices

Industry leaders must harness the momentum of technological and regulatory advances to secure a competitive edge. It is paramount to invest in automation and smart integration features that not only enhance product performance but also ensure compliance with the latest healthcare standards. Embracing digital transformation by linking devices with intelligent data analytics platforms can significantly improve real-time monitoring and quality control. Leaders should consider strategic partnerships and collaborative ventures that amplify innovation while reducing development risks.

Focusing on sustainable materials and versatile design can further differentiate products in an increasingly crowded marketplace. It is equally important to track market segmentation trends meticulously-ensuring product portfolios are well-aligned with distinct clinical and demographic needs. By tailoring solutions for diverse end-user groups ranging from diagnostic centers to hospitals, companies can address unmet demands and secure long-term market share. Ultimately, a proactive approach to innovation combined with detailed market intelligence will empower organizations to navigate competitive challenges and tap into emerging opportunities effectively.

Conclusion of the Blood Collection Devices Market Analysis

In summary, the analysis of the blood collection devices market highlights a period of significant evolution and dynamic change. The ongoing drive towards automation, enhanced material efficiency, and improved safety measures has reshaped industry paradigms, pushing the market towards more innovative and precise solutions. Detailed segmentation insights demonstrate that product diversification-across product type, technology, material, application, and user demographics-plays a crucial role in meeting the intricate demands of modern healthcare settings. Regional trends further reveal that while technological advancements are uniform globally, localized market dynamics inject unique challenges and opportunities.

This comprehensive review affirms that continuous investment in research, innovation, and strategic market positioning is essential to remain at the forefront of this competitive field. Through a balanced approach that addresses both quality and efficiency, industry stakeholders are well-equipped to drive forward meaningful improvements in patient care and clinical diagnostics.

Product Code: MRR-742BD517BE69

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising awareness and demand for preventive healthcare fueling routine blood screening
  - 5.1.1.2. Expansion of point-of-care testing enabling faster diagnostics and personalized medicine
  - 5.1.1.3. Growing aging population contributing to higher utilization of blood diagnostics in healthcare
- 5.1.2. Restraints
  - 5.1.2.1. Safety and contamination issues associated with blood collection devices
- 5.1.3. Opportunities
  - 5.1.3.1. Integration of AI and IoT in blood collection devices to improve data accuracy and patient outcomes
  - 5.1.3.2. Increasing investments in R&D to develop multifunctional blood collection systems to streamline blood processing
- 5.1.4. Challenges
  - 5.1.4.1. Stringent safety and quality standards associated with blood collection devices
5.2. Market Segmentation Analysis
- 5.2.1. Product Type: Growing significance of blood collection tubes for specific diagnostic purposes
- 5.2.2. Application: Expanding applications of blood collection devices for diagnostic purposes to ascertain various diseases and health conditions
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Blood Collection Devices Market, by Product Type

6.1. Introduction
6.2. Blood Bags
6.3. Blood Collection Needles
- 6.3.1. Syringe Needles
- 6.3.2. Vacuum Needles
6.4. Blood Collection Tubes
- 6.4.1. EDTA Tubes
- 6.4.2. Heparin Tubes
- 6.4.3. Plasma Blood Tubes
- 6.4.4. Serum Tubes
6.5. Blood Lancets

7. Blood Collection Devices Market, by Technology

7.1. Introduction
7.2. Automated Blood Collection Devices
7.3. Manual Blood Collection Devices

8. Blood Collection Devices Market, by Material

8.1. Introduction
8.2. Glass
8.3. Plastic
8.4. Rubber
8.5. Stainless Steel

9. Blood Collection Devices Market, by Application

9.1. Introduction
9.2. Diagnostics
9.3. Therapeutics

10. Blood Collection Devices Market, by End Users

10.1. Introduction
10.2. Blood Donation Centers
10.3. Diagnostic Centers & Pathology Laboratory
10.4. Hospitals & Clinics

11. Americas Blood Collection Devices Market

11.1. Introduction
11.2. Argentina
11.3. Bolivia
11.4. Brazil
11.5. Canada
11.6. Chile
11.7. Colombia
11.8. Costa Rica
11.9. Dominican Republic
11.10. Ecuador
11.11. Guatemala
11.12. Mexico
11.13. Panama
11.14. Paraguay
11.15. Peru
11.16. Puerto Rico
11.17. United States

12. Asia-Pacific Blood Collection Devices Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Blood Collection Devices Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Scenario Analysis
- 14.3.1. Haemonetics divests whole blood assets to GVS, S.p.A strategic pivot towards apheresis focus and enhanced growth initiatives
- 14.3.2. BD and Babson Diagnostics revolutionize blood collection with fingertip testing to enhance accessibility and efficiency across the US healthcare sector
- 14.3.3. Kriya Medical Technologies secures CE mark for blood collection tubes, paving new pathways in the European IVDR compliance landscape.
- 14.3.4. Metropolis Healthcare revolutionizes patient experience with UltraTouch advanced blood collection devices
- 14.3.5. Nipro Innovates in Blood Collection with Introduction of a Novel Air-Free Design
- 14.3.6. BD Secures FDA 510(k) Clearance for Innovative Fingertip Blood Collection Device
- 14.3.7. BD's Introduction of Needle-Free Device to Enhance Patient Comfort
- 14.3.8. Aptar and Tasso's Alliance to Revolutionize Blood Collection with Digital Integration
- 14.3.9. FDA Grants Clearance to YourBio Health's Innovative Blood Collection Device, Enhancing Efficiency and Patient Experience
- 14.3.10. Capitainer Unveils Innovative Self-Sampling Blood Collection Kit, Elevating Diagnostic Efficiency
- 14.3.11. Babson College and BD's Strategic Alliance for Enhanced Accessibility and Efficiency in Healthcare
- 14.3.12. Owen Mumford's Unveils Innovative Blood Collection Devices Enhancing Safety and Efficiency
- 14.3.13. Introducing RNA Complete BCT Revolutionizing Blood Collection with Enhanced Cell-Free RNA and Extracellular Vesicle Preservation
14.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abbott Laboratories
2. AdvaCare Pharma
3. Avanos Medical, Inc.
4. Avantor, Inc.
5. B. Braun SE
6. Becton, Dickinson and Company
7. Bio-Rad Laboratories, Inc.
8. Biosigma S.p.A.
9. Cardinal Health, Inc.
10. Exelint International, Co.
11. Fresenius SE & Co. KGaA
12. Greiner AG
13. Haemonetics Corporation by GVS S.p.A.
14. ICU Medical, Inc.
15. Kawasumi Laboratories America, Inc.
16. Lasany International
17. Medtronic PLC
18. Merit Medical Systems, Inc.
19. Nipro Corporation
20. Sarstedt AG & Co. KG
21. Sekisui Medical Co., Ltd.
22. Siemens Healthineers AG
23. Terumo Corporation
24. Thermo Fisher Scientific Inc.